220 related articles for article (PubMed ID: 16784314)
1. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience.
Fischer M; Schwabe C; Schulte KL
J Endovasc Ther; 2006 Jun; 13(3):281-90. PubMed ID: 16784314
[TBL] [Abstract][Full Text] [Related]
2. [Hemobahn-endoprosthesis: long-term experience (< or = 4 years follow-up) with percutaneous application in stenoses and occlusions of the superficial femoral artery].
Fischer M; Langhoff R; Schulte KL
Zentralbl Chir; 2003 Sep; 128(9):740-5. PubMed ID: 14533042
[TBL] [Abstract][Full Text] [Related]
3. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
4. The role of superficial femoral artery endoluminal bypass in long de novo lesions and in-stent restenosis.
Doomernik DE; Golchehr B; Lensvelt MM; Reijnen MM
J Cardiovasc Surg (Torino); 2012 Aug; 53(4):447-57. PubMed ID: 22854524
[TBL] [Abstract][Full Text] [Related]
5. [Hemobahn endoprosthesis: experience with percutaneous placing in the arteria femoralis superficialis].
Fischer M; Sakriss U; Stalke J; Schulte KL
Zentralbl Chir; 2001 Feb; 126(2):138-43. PubMed ID: 11253539
[TBL] [Abstract][Full Text] [Related]
6. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency?
Alimi YS; Hakam Z; Hartung O; Boufi M; Barthèlemy P; Aissi K; Dubuc M
Eur J Vasc Endovasc Surg; 2008 Mar; 35(3):346-52. PubMed ID: 17983772
[TBL] [Abstract][Full Text] [Related]
8. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
9. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent.
Lenti M; Cieri E; De Rango P; Pozzilli P; Coscarella C; Bertoglio C; Troiani R; Cao P
J Vasc Surg; 2007 Jan; 45(1):32-9. PubMed ID: 17210380
[TBL] [Abstract][Full Text] [Related]
10. Outcome of thrombolysis and thrombectomy for thrombosed endografts inserted in the superficial femoral artery for occlusive disease.
Golchehr B; Lensvelt MM; Fritschy WM; Holewijn S; van Walraven LA; van Oostayen JA; Zeebregts CJ; Reijnen MM
J Endovasc Ther; 2013 Dec; 20(6):836-43. PubMed ID: 24325702
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease.
Kedora J; Hohmann S; Garrett W; Munschaur C; Theune B; Gable D
J Vasc Surg; 2007 Jan; 45(1):10-6; discussion 16. PubMed ID: 17126520
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of longitudinal femoropopliteal vascular lesions with stents--report of individual cases].
Lugmayr H; Holzer H; Riedelsberger H
Rofo; 1999 Feb; 170(2):205-8. PubMed ID: 10101363
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
Kudo T; Chandra FA; Ahn SS
J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft.
Bray PJ; Robson WJ; Bray AE
J Endovasc Ther; 2003 Jun; 10(3):619-28. PubMed ID: 12932177
[TBL] [Abstract][Full Text] [Related]
15. Placement of Hemobahn stent-grafts in femoropopliteal arteries: early experience and midterm results in 18 patients.
Deutschmann HA; Schedlbauer P; Bérczi V; Portugaller H; Tauss J; Hausegger KA
J Vasc Interv Radiol; 2001 Aug; 12(8):943-50. PubMed ID: 11487674
[TBL] [Abstract][Full Text] [Related]
16. Duplex-guided balloon angioplasty and stenting for femoropopliteal arterial occlusive disease: an alternative in patients with renal insufficiency.
Ascher E; Marks NA; Schutzer RW; Hingorani AP
J Vasc Surg; 2005 Dec; 42(6):1108-13. PubMed ID: 16376200
[TBL] [Abstract][Full Text] [Related]
17. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Peeters P
J Endovasc Ther; 2015 Feb; 22(1):1-10. PubMed ID: 25775672
[TBL] [Abstract][Full Text] [Related]
18. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft.
Farraj N; Srivastava A; Pershad A
J Invasive Cardiol; 2009 Jun; 21(6):278-81. PubMed ID: 19494404
[TBL] [Abstract][Full Text] [Related]
19. [Factors determining late patency of aortobifemoral bypass graft].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
[TBL] [Abstract][Full Text] [Related]
20. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease.
Saxon RR; Dake MD; Volgelzang RL; Katzen BT; Becker GJ
J Vasc Interv Radiol; 2008 Jun; 19(6):823-32. PubMed ID: 18503895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
